Skip to main content
Aarti Pharmalabs Limited logo

Aarti Pharmalabs Limited — Investor Relations & Filings

Ticker · AARTIPHARM ISIN · INE0LRU01027 LEI · 335800TTAKRBNDK5P363 BSE.NS Manufacturing
Open in API
Filings indexed 246 across all filing types
Latest filing 2023-05-03 Board/Management Inform…
Country IN India
Listing BSE.NS AARTIPHARM

About Aarti Pharmalabs Limited

https://www.aartipharmalabs.com/

Aarti Pharmalabs Limited is a manufacturer of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and xanthine derivatives. The company specializes in the development and production of complex chemistry-based products for the global pharmaceutical and generic drug industries. Its core portfolio includes APIs across diverse therapeutic areas such as oncology, cardiovascular, and anti-diabetics. Additionally, the company is a major producer of xanthines, including caffeine and theophylline. Aarti Pharmalabs offers comprehensive Contract Development and Manufacturing Organization (CDMO) services, leveraging its integrated research and development capabilities and large-scale manufacturing facilities. The organization maintains high regulatory standards, ensuring compliance with international quality benchmarks to serve a global clientele.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results/Other business matters
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing them about an upcoming Board Meeting scheduled for May 12, 2023. The purpose of the meeting includes consideration and approval of audited financial results for the quarter and year ended March 31, 2023. The letter references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures about board meetings. The document does not contain the financial results or statements themselves but is an announcement of the meeting where these will be approved. The document length is short (1497 characters), and it serves as a notification rather than a report or detailed filing. Therefore, it fits the category of Board/Management Information (MANG), which covers announcements of board meetings and related management information.
2023-05-03 English
Price movement
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited regarding a clarification sought about significant price movement of the company's security. It references a regulatory letter and responds that there is no material event or information affecting the price, affirming compliance with SEBI regulations. The document is short (2012 characters) and is a regulatory communication or clarification rather than a financial report or announcement of results. It does not contain financial data, management discussion, or report content. It is not an announcement of a report publication but a regulatory filing responding to a query. Therefore, it fits best under Regulatory Filings (RNS).
2023-04-18 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate submitted under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2023. It is addressed to stock exchanges and is a compliance certificate related to shareholding or depository participant regulations. The document length is short (1211 characters) and it is a formal attestation rather than a financial report or detailed filing. It does not contain financial statements or detailed financial data. It is primarily a regulatory compliance certificate, which fits best under Regulatory Filings (RNS) as per the classification rules, especially the Certification Rule and fallback category for miscellaneous filings.
2023-04-07 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the closure of the trading window due to upcoming financial results announcement. It references SEBI (Prohibition of Insider Trading) Regulations, 2015, and specifies the trading window closure period around the financial results for the quarter and year ending March 31, 2023. The document does not contain any financial data, report content, or detailed analysis. It is a regulatory compliance announcement related to insider trading restrictions rather than a financial report or earnings release. The document length is short (1360 characters), and it serves as a notification to the exchanges rather than the report itself. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-03-29 English
Credit Rating
Capital/Financing Update Classification · 95% confidence The document is a letter from CRISIL Ratings assigning and confirming credit ratings for the bank facilities of Aarti Pharmalabs Ltd. It details the assigned ratings, the total bank loan facilities rated, and the validity period of the rating letter. The content focuses on credit rating assignment and surveillance rather than financial performance, management changes, or regulatory filings. It is not an annual report, earnings release, or audit report. It is also not a report publication announcement or certification. The document is a credit rating update related to the company's financing and debt instruments. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is about 5954 characters, which is sufficient for a detailed rating letter, not a brief announcement.
2023-03-03 English
Financial Result Updates
Interim / Quarterly Report Classification · 95% confidence The document is an auditor's report on the audit of standalone financial results for the nine months ended December 31, 2022. It includes detailed audit opinion, basis for opinion, management responsibilities, auditor responsibilities, and other matters related to the audit. The report references Indian Accounting Standard 34 'Interim Financial Reporting' and covers a period shorter than a full fiscal year (April 1, 2022 to December 31, 2022). The document contains substantive financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2023-02-13 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.